Putting presenilins centre stage. Introduction to the Talking Point on the role of presenilin mutations in Alzheimer disease

EMBO Reports

Volumn 8, Issue 2, 2007, Pages 134-135

  Hardy, John ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; BRAIN PROTEIN; GAMMA SECRETASE; NOTCH RECEPTOR; PRESENILIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; CONSENSUS; EDITORIAL; GENE MUTATION; HEMIZYGOSITY; HUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN TARGETING; WILD TYPE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID PRECURSOR PROTEIN SECRETASES; HUMANS; MUTATION; PRESENILINS; PROTEIN CONFORMATION;

EID: 33947198187     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/sj.embor.7400899     Document Type: Editorial

References (13)

1. Beglopoulos V, Shen J (2006) Regulation of CRE-dependent transcription by presenilins: Prospects for therapy of Alzheimer's disease. Trends Pharmacol Sci 27: 33-40
2. De Strooper B (2007) Loss of function presenilin mutations in Alzheimer disease. EMBO reports 8: 141-146
3. De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G, Annaert W, Von Figura K, Van Leuven F (1998) Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391: 387-390
4. Edbauer D, Winkler E, Regula JT, Pesold B, Steiner H, Haass C (2003) Reconstitution of γ-secretase activity. Nat Cell Biol 5: 486-488
5. Haass C, Selkoe DJ (1993) Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide. Cell 75: 1039-1042
6. Lazarov VK, Fraering PC, Ye W, Wolfe MS, Selkoe DJ (2006) Electron microscopic structure of a purified active γ secretase reveals an aqueous intramembranous chamber and two pores. Proc Natl Acad Sci USA 103: 16889-16894
7. Levitan D, Greenwald I (1995) Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 377: 351-354
8. Rogaeva E (2002) The solved and unsolved mysteries of the genetics of early-onset Alzheimer's disease. Neuromolecular Med 2: 1-10
9. Sambamurti K, Suram A, Venugopal C, Prakasam A, Zhou Y, Lahiri DK, Greig NH (2006) A partial failure of membrane protein turnover may cause Alzheimer's disease: A new hypothesis. Curr Alzheimer Res 3: 81-90
10. Scheuner D et al (1996) Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 2: 864-870
11. Spasic D, Tolia A, Dillen K, Baert V, De Strooper B, Vrijens S, Annaert W (2006) Presenilin-1 maintains a nine-transmembrane topology throughout the secretory pathway. J Biol Chem 281: 26569-26577
12. Wolfe MS (2007) When loss is gain: Reduced presenilin proteolytic function leads to increased Aβ42/Aβ40. EMBO reports 8: 136-140
13. Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Kimberly WT, Selkoe DJ (1999) Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity. Nature 398: 513-517